公司资料
Nuvectis Pharma 股价、新闻与催化剂
- 股票代码:
- NVCT
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
23.56 USD (+0.90%)
收盘价
最后更新: 2026年8月21日
252M USD
市值
股价为何变动
As of Aug 21, 2026, NVCT closed up 0.90% at $23.56. No new same-company headline was identified in the current news window.
公司概览
业务概览
Nuvectis Pharma is an oncology company focused on targeted therapies for difficult cancers. Its development story is centered on precision oncology and smaller, data-sensitive programs.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Nuvectis sits in specialty oncology biotechnology.
商业模式特征
The business depends on proof-of-concept, program prioritization, and the ability to build a differentiated oncology franchise.
生物医药行业定位
Nuvectis is a small-cap oncology catalyst name whose valuation can move sharply on early data.
未来催化剂
- Nuvectis’s catalysts are NXP900 and NXP800, the two oncology assets that define the story. The market will care about whether either program can show real differentiation.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。